Penfluridol
From Wikipedia, the free encyclopedia
 |
|
|
Penfluridol
|
|
| Systematic (IUPAC) name | |
| 1-[4,4-bis(4-fluorophenyl)butyl]-4-[4-chloro-3-(trifluoromethyl)phenyl]piperidin-4-ol | |
| Identifiers | |
| CAS number | |
| ATC code | N05 |
| PubChem | |
| Chemical data | |
| Formula | C28H27ClF5NO |
| Mol. mass | 523.965 |
| Pharmacokinetic data | |
| Bioavailability | ? |
| Metabolism | ? |
| Half life | ? |
| Excretion | ? |
| Therapeutic considerations | |
| Pregnancy cat. |
? |
| Legal status | |
| Routes | ? |
Penfluridol is a piperidine antipsychotic. It was discovered at Janssen Pharmaceutica in 1968.
[edit] References
- Janssen PA, Niemegeers CJ, Schellekens KH, Lenaerts FM, Verbruggen FJ, Van Nueten JM, Schaper WK., The pharmacology of penfluridol (R 16341) a new potent and orally long-acting neuroleptic drug, Eur J Pharmacol. 1970 Jul 15;11(2):139-54.
- van Praag HM, Schut T, Dols L, van Schilfgaarden R., Controlled trial of penfluridol in acute psychosis,
Br Med J. 1971 Dec 18;4(5789):710-3.
 |
This pharmacology-related article is a stub. You can help Wikipedia by expanding it. |
